3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Tuberous Sclerosis
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lymphangioleiomyomatosis
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
HER2-positive Breast Cancer
1
Castleman Disease
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
Biopsy
2
trastuzumab biosimilar HLX02
1
pembrolizumab
1
Watchful Waiting
1
Transcutaneous Electric Nerve Stimulation
1
Standard of Care
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Observation
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Genetic Testing
×
30 days
×
Clear all
No trials found.